Join to View Full Profile
513 Parnassus Ave S321San Francisco, CA 94143
Phone+1 415-476-1239
Dr. Chu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Carissa Chu is a San Francisco-based urologist who completed her medical education at the University of California San Francisco School of Medicine in 2014 and a surgical residency there from 2014 to 2015. She has contributed several publications to the field, focusing on various aspects of urothelial carcinoma and its treatment. Her research includes work on molecular heterogeneity, immune infiltration, and specific gene alterations in urothelial carcinoma, with her studies appearing in journals like European Urology and Clinical Cancer Research. She has also explored women's perspectives on sexual function post-radical cystectomy and the use of non-invasive testing in bladder cancer management.
Education & Training
University of California (San Francisco)Residency, Surgery, 2014 - 2015- University of California San Francisco School of MedicineClass of 2014
Certifications & Licensure
CA State Medical License 2016 - 2025
NY State Medical License 2021 - 2024
Publications & Presentations
PubMed
- Felix Feng (1975-2024).Carissa Chu, David Quigley
Nature Cancer. 2025-04-18 - Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial Carcinoma.Kwanghee Kim, Syed M Alam, Fengshen Kuo, Ziyu Chen, Wesley Yip
European Urology. 2025-03-01 - 3 citationsHER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gains.Xiaolin Zhu, Emily Chan, Michelle L Turski, Carlos Espinosa Mendez, Sarah C Hsu
The Oncologist. 2024-08-05
Press Mentions
Felix Feng, Giant in the Field of Prostate Cancer, Dies at 48January 22nd, 2025- Clinical Challenges: Can MRI and Biomarkers Replace Biopsy for AS in Prostate Cancer?December 2nd, 2020
Other Languages
- Spanish, Chinese (Cantonese)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
